Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ALLERGAN PLC
01/22 WILLIAM ACKMAN : Ackman cuts staff, shuns limelight as he seeks to turn around f..
01/19 AMGEN : EC approves Amgen's biosimilar Avastin
01/18 ALLERGAN : European Commission Approves Amgen And Allergan's MVASI® (Biosimilar ..
01/17 Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS P..
01/17 Allergan Pact Advances -- WSJ
01/17 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 ALLERGAN : Ironwood and Allergan Announce Settlement with Sun Pharma Resolving L..
01/13 ALLERGAN : Evolus Files for IPO Ahead of Potential 2018 Approval for Botox Alter..
01/11 ALLERGAN : 2 Reasons Why Allergan Stock Plunged in 2017
01/09 U.S. pharma executives expect deals to pick up after tax overhaul
01/09 ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
01/08 ALLERGAN : Provides 2018 Preliminary Financial Outlook for Select Income Stateme..
01/08 ALLERGAN : to Report Fourth Quarter and Full Year 2017 Earnings and Host Confere..
01/03 ALLERGAN : to cut over 1,000 jobs as it works to cut costs
More most relevant news
All news about ALLERGAN PLC
01/22 WILLIAM ACKMAN : Ackman cuts staff, shuns limelight as he seeks to turn around f..
01/20 ALLERGAN : Factory Mutual Insurance Co. Increases Holdings in Allergan plc (AGN)
01/19 AMGEN : EC approves Amgen's biosimilar Avastin
01/18 ALLERGAN : European Commission Approves Amgen And Allergan's MVASI® (Biosimilar ..
01/17 Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS P..
01/17 Allergan Pact Advances -- WSJ
01/17 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 ALLERGAN : Ironwood and Allergan Announce Settlement with Sun Pharma Resolving L..
01/13 ALLERGAN : Evolus Files for IPO Ahead of Potential 2018 Approval for Botox Alter..
More news
Sector news : Pharmaceuticals - NEC
01/22 WILLIAM ACKMAN : Ackman cuts staff, shuns limelight as he seeks to turn around f..
01/22 Stocks hit record as senators reach deal to end shutdown
01/22 Canada's small financial firms get buzz from weed stocks
01/22 Big Drugmakers Pay Big Prices for Promising Biotechs
01/22 Dealmaking drives European stocks as equity melt-up continues
01/22 UK stocks decline as gamblers stumble on government clampdown worries
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/21 Top 10 Net Payout Yields For January 2018
01/20 YOUR DAILY PHARMA SCOOP : Ablynx Takeover Battle, Acorda Takeover Speculation, O..
01/18 EC OKs Amgen's Avastin biosimilar
01/18 Big Biopharma in the red in early trade
01/16 ALLERGAN : Insiders Buy; Investors Shy Away
01/16 FDA launches new program to boost transparency of clinical data used to suppo..
Latest Tweets
01/22Kirr Marbach & Co. LLC IN Sells 886 Shares of Allergan plc $AGN  
01/22S&CO Inc. Acquires 1,075 Shares of Allergan plc $AGN  
01/22A new FDA policy wades into heated battles between drug makers and compounder.. 
01/22Allergan plc $AGN Stake Decreased by Koshinski Asset Management Inc.  
01/20$WPI ALERT: New Allergan plc SEC Filing From our Stock News Alerts App 
More tweets
Qtime:186
Financials ($)
Sales 2017 15 892 M
EBIT 2017 7 624 M
Net income 2017 -6 499 M
Debt 2017 24 894 M
Yield 2017 1,58%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,36x
EV / Sales 2018 5,45x
Capitalization 60 307 M
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | AGN | IE00BY9D5467 | 4-Traders
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 217 $
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
James H. Bloem Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC10.85%60 307
JOHNSON & JOHNSON5.47%395 886
NOVARTIS1.19%227 592
PFIZER1.99%220 189
ROCHE HOLDING LTD.-4.87%211 135
MERCK AND COMPANY8.90%167 132